Syntegra Private Wealth Group’s West Pharmaceutical WST Stock Holding History

Syntegra Private Wealth Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-14,756	Closed	-$4.06M	–	200
2025 Q4	$4.06M	Hold	14,756	–	–	0.37%	33
2025 Q3	$3.87M	Hold	14,756	–	–	0.37%	32
2025 Q2	$3.23M	Buy	14,756 +5	+0%	+$1.07K	0.33%	32
2025 Q1	$3.3M	Hold	14,751	–	–	0.39%	26
2024 Q4	$4.83M	Hold	14,751	–	–	0.55%	23
2024 Q3	$4.43M	Hold	14,751	–	–	0.51%	24
2024 Q2	$4.86M	Hold	14,751	–	–	0.62%	20
2024 Q1	$5.84M	Hold	14,751	–	–	0.75%	18
2023 Q4	$5.19M	Sell	14,751 -9,800	-40%	-$3.47M	0.73%	20
2023 Q3	$9.21M	Sell	24,551 -5	-0%	-$1.93K	1.45%	16
2023 Q2	$9.39M	Buy	24,556 +5	+0%	+$1.79K	1.44%	17
2023 Q1	$8.51M	Hold	24,551	–	–	1.51%	16
2022 Q4	$5.78M	Buy	+24,551	New	+$5.82M	1.16%	16

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Syntegra Private Wealth Group's WST Position: Q1 2026 in Review

Syntegra Private Wealth Group sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 14,756 shares — an estimated $4.06M sold.

Syntegra Private Wealth Group first reported a position in WST in Q4 2022 and held it in 13 quarters. The position peaked at $9.39M in Q2 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

Syntegra Private Wealth Group reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
Syntegra Private Wealth Group sold 14,756 West Pharmaceutical shares in Q1 2026, an estimated $4.06M.
Syntegra Private Wealth Group first reported a position in West Pharmaceutical in Q4 2022 and held it in 13 quarters.
Syntegra Private Wealth Group's West Pharmaceutical position peaked at $9.39M in Q2 2023.
755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Syntegra Private Wealth Group's 13F filing for Q1 2026, filed 27 Apr 2026.